Yatharth Hospital Q4FY26 Monitoring Agency Report for QIP Proceeds
Yatharth Hospital submitted its QIP Monitoring Agency Report for Q4FY26. For the quarter ended December 31, 2025, ₹432.69 million of QIP proceeds were utilized. This included ₹2,173.19 million for hospital acquisitions and ₹836.39 million for medical equipment. The company also utilized ₹1,252.27 million for general corporate purposes.
This is a routine disclosure as per SEBI regulations for monitoring QIP proceeds. It does not introduce any new material information that would significantly affect the company's stock or business operations.
The announcement is a routine regulatory filing regarding the utilization of QIP proceeds and does not contain any new financial performance data or significant business updates that would positively or negatively impact the company's outlook.
Yatharth Hospital & Trauma Care Services Limited has submitted the Monitoring Agency Report for the quarter ended December 31, 2025, concerning the utilization of proceeds from its Qualified Institutional Placement (QIP). The report, issued by Crisil Ratings Limited, confirms that the utilization of QIP proceeds is in line with the objects disclosed in the offer document.
During the quarter, the company utilized ₹432.69 million towards the objects of the issue. This included ₹2,173.19 million for the acquisition costs of two hospitals in Model Town, Delhi, and Faridabad, Haryana, and ₹836.39 million for the purchase of medical equipment, with ₹387.66 million remaining to be utilized in Fiscal 2026. Additionally, ₹1,252.27 million was utilized for general corporate purposes.
The company has fully utilized the ₹956.80 million earmarked for the repayment of borrowings. The Audit Committee reviewed and noted the Monitoring Agency Report in its meeting held on February 05, 2026. The report is available on the company's website.
What to do with a filing like this
Yatharth Hospital & Trauma Care Services Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Yatharth Hospital & Trauma Care Services Limited. Read the original for the full detail.